Connect with us

Hi, what are you looking for?

Jewish Business News


Israeli Startup CorNeat Has Brought Eyesight to the Blind – Literally

Its KPro Implant replaces the cornea.

Prof. Irit Bahar and Her patient (CorNeat)

CorNeat Vision, an Israeli startup that develops biomimetic implant technology, has successfully restored the vision of a 78-year-old man who had been blind for 10 years. The procedure was performed at the Rabin Medical Center in Israel.

The surgery was performed on a bilaterally blind patient by Professor Irit Bahar, Director of the hospital’s Ophthalmology Department.

The Who have a famous song from their classic rock opera Tommy called “Eyesight to the Blind.” The song is about a woman so powerful that, as the lyric goes, “Every time she starts to lovin’ She brings eyesight to the blind.”

And the Bible is filled with references to God healing the blind. Psalm 146:8 reads, “The Lord gives sight to the blind, the Lord lifts up those who are bowed down, the Lord loves the righteous.” Isaiah 29:18 says, “In that day the deaf will hear the words of the scroll, and out of gloom and darkness the eyes of the blind will see.”

Well now advanced science and technology can cure blindness.

Prof. Irit Bahar and Dr. Gilad Litvin, together with the first-in-human KPro patient and his daughter, the moment his sight returned.

Established in 2015 and based in Ra’anana, CorNeat Vision is an ophthalmic medical device company who declares its mission to be to promote human health, sustainability and equality worldwide. CorNeat Vision produces a lineup of innovative, safe, affordable and long-lasting ophthalmic medical solutions, including the CorNeat KPro and the CorNeat EverPatch. Its products can improve ophthalmic surgery practices in the areas of cornea, sclera, glaucoma (trabecular mesh), myopia and more.

The CorNeat KPro implant is designed to replace deformed, scarred or opacified corneas. The company states that this implant is expected to “fully and immediately rehabilitate” the vision of corneally blind patients following an implantation procedure. The CorNeat Boasts that its KPro will transform global corneal therapy and provide, for the first time, a reliable and scalable synthetic substitute to the human cornea, significantly impacting the lives of millions of people with cornea-related visual impairments and blindness.

Dr. Gilad Litvin, CorNeat Vision’s Co-Founder, Chief Medical Officer, and the inventor of the CorNeat KPro:

“Unveiling this first implanted eye and being in that room, in that moment, was surreal. After years of hard work, seeing a colleague implant the CorNeat KPro with ease and witnessing a fellow human being regain his sight the following day was electrifying and emotionally moving, there were a lot of tears in the room. This is an extremely important milestone for CorNeat Vision, key in our journey to enable people around the world to fully enjoy their vision potential. I am grateful and honored to work with an outstanding group of people whose hard work, diligence and creativity, made this moment possible.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.